Clinical Utility of β-Amyloid PET Imaging in People Living With HIV With Cognitive Symptoms.

Background: Imaging with β-amyloid (Aβ) positron emission tomography (PET) has the potential to aid the diagnosis of the cause of cognitive impairment affecting people living with HIV (PLWH) when neurodegenerative disorders are considered. We evaluated the clinical utility of [18F]Florbetaben (FBB) in PLWH with cognitive symptoms.

Methods: Imaging with FBB PET was performed in 20 patients with cognitive concerns about dementia.